Literature DB >> 33833415

Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?

Yuwei Wang1,2, Qiyu Bo1,2, Huixun Jia1,2, Mengsha Sun1,2, Yang Yu1, Peirong Huang1,2, Jing Wang1,2, Nana Xu1,2, Fenghua Wang3,4,5, Hong Wang6,7,8, Xiaodong Sun1,2,9.   

Abstract

PURPOSE: To evaluate the diagnostic accuracy of spectral-domain optical coherence tomography (SD-OCT) and swept-source optical coherence tomographic angiography (SS-OCTA) to identify polypoidal lesions in serous or serosanguinous maculopathy.
MATERIALS AND METHODS: A retrospective review of patients presenting pigment epithelial detachments (PEDs) with the diagnosis of polypoidal choroidal vasculopathy (PCV), neovascular age-related macular degeneration (nAMD), and central serous chorioretinopathy (CSC), all of which underwent SD-OCT, SS-OCTA, and indocyanine green angiography (ICGA). Typical features of polypoidal lesions on SD-OCT included sharply peaked PED, notched PED, and hyperreflective ring underneath PED. SS-OCTA feature was vascularized PEDs on cross-sectional images corresponding to cluster-like structures on en face images. The parameters of PEDs were measured for analysis.
RESULTS: Of 72 eyes, 30 had PCV, 22 had nAMD, and 20 had CSC. A total of 128 localized PEDs were detected on SD-OCT. Typical features on SD-OCT had a high specificity (94.0%) but a limited sensitivity (73.8%). SS-OCTA features provided a higher sensitivity (96.7%). PEDs of the polypoidal lesions unrecognized by SD-OCT were dome-shaped, with smaller ratio of height to base diameter and less area, and almost had heterogeneous internal reflectivity and a connected double-layer sign. Some lesions misidentified by SS-OCTA developed into ICGA-proven polypoidal lesions at follow-up visits.
CONCLUSION: A small dome-shaped PED with heterogeneous internal reflectivity and a connected double-layer sign on SD-OCT may suggest a polypoidal lesion of PCV. SS-OCTA may be a helpful tool to investigate preclinical PCV and observe the formation of polypoidal lesions.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33833415      PMCID: PMC8956584          DOI: 10.1038/s41433-020-01390-0

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  50 in total

1.  Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.

Authors:  Gabriella De Salvo; Sara Vaz-Pereira; Pearse A Keane; Adnan Tufail; Gerald Liew
Journal:  Am J Ophthalmol       Date:  2014-08-22       Impact factor: 5.258

2.  POLYPOIDAL CHOROIDAL VASCULOPATHY UPON OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY.

Authors:  Szy Yann Chan; Qian Wang; Ya Xing Wang; Xue Hui Shi; Jost B Jonas; Wen Bin Wei
Journal:  Retina       Date:  2018-06       Impact factor: 4.256

3.  Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.

Authors:  K Takayama; Y Ito; H Kaneko; K Kataoka; T Sugita; R Maruko; K Hattori; E Ra; F Haga; H Terasaki
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

4.  Prevalence and Severity of Artifacts in Optical Coherence Tomographic Angiograms.

Authors:  Ian C Holmen; Sri Meghana Konda; Jeong W Pak; Kyle W McDaniel; Barbara Blodi; Kimberly E Stepien; Amitha Domalpally
Journal:  JAMA Ophthalmol       Date:  2020-02-01       Impact factor: 7.389

5.  Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy.

Authors:  Daniel S W Ting; Gemmy C M Cheung; Laurence S Lim; Ian Y S Yeo
Journal:  Clin Exp Ophthalmol       Date:  2015-08-06       Impact factor: 4.207

6.  IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA.

Authors:  Chui Ming Gemmy Cheung; Augustinus Laude; Wanling Wong; Ranjana Mathur; Choi Mun Chan; Edmund Wong; Doric Wong; Tien Yin Wong; Tock Han Lim
Journal:  Retina       Date:  2015-07       Impact factor: 4.256

7.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

8.  Pigment epithelial detachment in polypoidal choroidal vasculopathy.

Authors:  Akitaka Tsujikawa; Manabu Sasahara; Atsushi Otani; Norimoto Gotoh; Takanori Kameda; Daisuke Iwama; Yuko Yodoi; Hiroshi Tamura; Michiko Mandai; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2006-09-28       Impact factor: 5.258

9.  Photodynamic therapy with or without intravitreal bevacizumab for polypoidal choroidal vasculopathy: two years of follow-up.

Authors:  Yi-An Lee; Chang-Hao Yang; Chung-May Yang; Tzyy-Chang Ho; Chang-Ping Lin; Jen-Sheng Huang; Muh-Shy Chen
Journal:  Am J Ophthalmol       Date:  2012-07-24       Impact factor: 5.258

10.  Evaluating Polypoidal Choroidal Vasculopathy With Optical Coherence Tomography Angiography.

Authors:  Min Wang; Yao Zhou; Simon S Gao; Wei Liu; Yongheng Huang; David Huang; Yali Jia
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.